Via AVACThe report tracks the public, philanthropic and commercial investment in biomedical HIV prevention in 2009 including preventive and therapeutic HIV vaccines, microbicides, oral pre-exposure prophylaxis (PrEP), adult male circumcision, prevention of mother to child transmission, and HSV-2 suppression and prevention. The report finds stability in funding for HIV prevention research from 2008 to 2009. HIV vaccines Read More >>

The HIV prevention world is abuzz with excitement following news of the first clinical evidence that a vaginal gel – known as a microbicide – can help to prevent sexual transmission of HIV infection. A study by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) found that a vaginal gel containing the antiretroviral Read More >>

IRMA media releaseIRMA Presses for Intensified Rectal Microbicide Research Quarraisha Abdool Karim (left) and Salim Abdool Karim,  co-principal investigators of the CAPRISA 004 trial. Vienna, Austria July 19, 2010 – Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered Read More >>

via IRMA member Rober Reinhard: An interesting paper was published today about HSV-2 suppression to reduce HIV transmission among partners, describing the largest cohort of serodiscordant couples ever organized. It also contains an important explanation of the differences between reducing “transmission” and reducing “acquisition” that affect understanding of the “ACE” prevention study results. An amazing effort which Read More >>

via Aidsmap Scientists at Harvard Medical School have succeeded in protecting mice against herpes infection for one week using a single application of a microbicide based on a new technology called RNA interference. The technology, still in its infancy as a therapeutic tool, could have a powerful impact as an HIV prevention tool, according to Professor Judy Read More >>